BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28338014)

  • 1. Entropic stabilization of a deubiquitinase provides conformational plasticity and slow unfolding kinetics beneficial for functioning on the proteasome.
    Lee YC; Chang CY; Chen SY; Pan YR; Ho MR; Hsu SD
    Sci Rep; 2017 Mar; 7():45174. PubMed ID: 28338014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topologically knotted deubiquitinases exhibit unprecedented mechanostability to withstand the proteolysis by an AAA+ protease.
    Sriramoju MK; Chen Y; Lee YC; Hsu SD
    Sci Rep; 2018 May; 8(1):7076. PubMed ID: 29728659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Length of the active-site crossover loop defines the substrate specificity of ubiquitin C-terminal hydrolases for ubiquitin chains.
    Zhou ZR; Zhang YH; Liu S; Song AX; Hu HY
    Biochem J; 2012 Jan; 441(1):143-9. PubMed ID: 21851340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of UCH-L5 activation and inhibition by DEUBAD domains in RPN13 and INO80G.
    Sahtoe DD; van Dijk WJ; El Oualid F; Ekkebus R; Ovaa H; Sixma TK
    Mol Cell; 2015 Mar; 57(5):887-900. PubMed ID: 25702870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain.
    Nishio K; Kim SW; Kawai K; Mizushima T; Yamane T; Hamazaki J; Murata S; Tanaka K; Morimoto Y
    Biochem Biophys Res Commun; 2009 Dec; 390(3):855-60. PubMed ID: 19836345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Knotted Protein UCH-L1 Exhibits Partially Unfolded Forms under Native Conditions that Share Common Structural Features with Its Kinetic Folding Intermediates.
    Lou SC; Wetzel S; Zhang H; Crone EW; Lee YT; Jackson SE; Hsu SD
    J Mol Biol; 2016 Jun; 428(11):2507-2520. PubMed ID: 27067109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration.
    Sharma A; Liu H; Tobar-Tosse F; Chand Dakal T; Ludwig M; Holz FG; Loeffler KU; Wüllner U; Herwig-Carl MC
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasomal deubiquitinase UCH37 inhibits degradation of β-catenin and promotes cell proliferation and motility.
    Li Z; Zhou L; Jiang T; Fan L; Liu X; Qiu X
    Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):277-284. PubMed ID: 30726867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism.
    VanderLinden RT; Hemmis CW; Yao T; Robinson H; Hill CP
    J Biol Chem; 2017 Jun; 292(23):9493-9504. PubMed ID: 28442575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
    Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
    Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin recognition of BAP1: understanding its enzymatic function.
    Hanpude P; Bhattacharya S; Kumar Singh A; Kanti Maiti T
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28935764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate.
    Misaghi S; Galardy PJ; Meester WJ; Ovaa H; Ploegh HL; Gaudet R
    J Biol Chem; 2005 Jan; 280(2):1512-20. PubMed ID: 15531586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
    Vander Linden RT; Hemmis CW; Schmitt B; Ndoja A; Whitby FG; Robinson H; Cohen RE; Yao T; Hill CP
    Mol Cell; 2015 Mar; 57(5):901-911. PubMed ID: 25702872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing substrate selectivity of ubiquitin C-terminal hydrolase-L3 using engineered α-linked ubiquitin substrates.
    Navarro MF; Carmody L; Romo-Fewell O; Lokensgard ME; Love JJ
    Biochemistry; 2014 Dec; 53(51):8031-42. PubMed ID: 25369561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-over Loop Cysteine C152 Acts as an Antioxidant to Maintain the Folding Stability and Deubiquitinase Activity of UCH-L1 Under Oxidative Stress.
    Puri S; Hsu SD
    J Mol Biol; 2021 Apr; 433(8):166879. PubMed ID: 33617897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of ubiquitin c-terminal hydrolases in oncogenesis.
    Fang Y; Fu D; Shen XZ
    Biochim Biophys Acta; 2010 Aug; 1806(1):1-6. PubMed ID: 20302916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untangling the folding mechanism of the 5(2)-knotted protein UCH-L3.
    Andersson FI; Pina DG; Mallam AL; Blaser G; Jackson SE
    FEBS J; 2009 May; 276(9):2625-35. PubMed ID: 19476499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of human Uch37.
    Burgie SE; Bingman CA; Soni AB; Phillips GN
    Proteins; 2012 Feb; 80(2):649-54. PubMed ID: 21953935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the Folding of a 5
    Zhang H; Jackson SE
    Biophys J; 2016 Dec; 111(12):2587-2599. PubMed ID: 28002735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting UCH-L5: Rational Design of a Cyclic Ubiquitin-Based Peptide Inhibitor.
    Hameed DS; Ovaa H; van der Heden van Noort GJ; Sapmaz A
    Front Mol Biosci; 2022; 9():866467. PubMed ID: 35720124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.